CompanyHealthAi
Ampersand Biomedicines
Ampersand Biomedicines is a Boston-area biotech founded by Flagship Pioneering that builds programmable biologic medicines designed to act only where disease lives. Its computational Address, Navigate, Determine (AND) Platform maps the body for ideal localization targets and designs AND-Body Therapeutics that anchor at a disease site and conditionally switch on biology there, aiming to widen the therapeutic window and cut the off-tissue side effects that limit conventional drugs.
2020Founded
BostonHQ
$65 millionSeries B
biotechbiotechnologyantibody engineeringtargeted therapeuticsprogrammable medicinesand-body